Revance Therapeutics, Inc. (RVNC)
USD 3.65
(0.0%)
USD 3.65
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -323.98 Million USD | 9.1% |
| 2022 | -356.42 Million USD | -24.27% |
| 2021 | -286.82 Million USD | -1.68% |
| 2020 | -282.08 Million USD | -80.58% |
| 2019 | -156.21 Million USD | -9.57% |
| 2018 | -142.56 Million USD | -18.23% |
| 2017 | -120.58 Million USD | -35.08% |
| 2016 | -89.27 Million USD | -21.5% |
| 2015 | -73.47 Million USD | -16.78% |
| 2014 | -62.91 Million USD | -19.96% |
| 2013 | -52.44 Million USD | 9.97% |
| 2012 | -58.25 Million USD | -29.86% |
| 2011 | -44.86 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -37.47 Million USD | 29.5% |
| 2024 Q1 | -53.15 Million USD | 4.57% |
| 2023 Q3 | -141.17 Million USD | -109.72% |
| 2023 FY | -323.98 Million USD | 9.1% |
| 2023 Q4 | -55.69 Million USD | 60.55% |
| 2023 Q2 | -67.31 Million USD | -1.92% |
| 2023 Q1 | -66.05 Million USD | 54.31% |
| 2022 Q4 | -144.55 Million USD | -70.68% |
| 2022 FY | -356.42 Million USD | -24.27% |
| 2022 Q1 | -64.38 Million USD | -2.04% |
| 2022 Q2 | -61.49 Million USD | 4.49% |
| 2022 Q3 | -84.69 Million USD | -37.72% |
| 2021 Q3 | -74.37 Million USD | -3.02% |
| 2021 Q2 | -72.19 Million USD | -0.78% |
| 2021 Q1 | -71.63 Million USD | 8.52% |
| 2021 Q4 | -63.09 Million USD | 15.16% |
| 2021 FY | -286.82 Million USD | -1.68% |
| 2020 Q2 | -60.59 Million USD | 2.17% |
| 2020 Q1 | -61.93 Million USD | -36.64% |
| 2020 FY | -282.08 Million USD | -80.58% |
| 2020 Q4 | -78.3 Million USD | 3.63% |
| 2020 Q3 | -81.25 Million USD | -34.11% |
| 2019 Q1 | -35.3 Million USD | 13.08% |
| 2019 FY | -156.21 Million USD | -9.57% |
| 2019 Q4 | -45.32 Million USD | -9.46% |
| 2019 Q3 | -41.4 Million USD | -10.75% |
| 2019 Q2 | -37.39 Million USD | -5.91% |
| 2018 Q3 | -32.83 Million USD | 3.66% |
| 2018 FY | -142.56 Million USD | -18.23% |
| 2018 Q1 | -35.03 Million USD | 2.42% |
| 2018 Q2 | -34.08 Million USD | 2.73% |
| 2018 Q4 | -40.61 Million USD | -23.7% |
| 2017 FY | -120.58 Million USD | -35.08% |
| 2017 Q1 | -27.15 Million USD | -1.32% |
| 2017 Q2 | -26.87 Million USD | 1.04% |
| 2017 Q3 | -30.65 Million USD | -14.05% |
| 2017 Q4 | -35.9 Million USD | -17.14% |
| 2016 Q1 | -19.88 Million USD | 9.98% |
| 2016 FY | -89.27 Million USD | -21.5% |
| 2016 Q4 | -26.8 Million USD | -49.08% |
| 2016 Q3 | -17.97 Million USD | 26.92% |
| 2016 Q2 | -24.6 Million USD | -23.7% |
| 2015 FY | -73.47 Million USD | -16.78% |
| 2015 Q3 | -19.17 Million USD | -14.1% |
| 2015 Q4 | -22.09 Million USD | -15.22% |
| 2015 Q2 | -16.8 Million USD | -9.11% |
| 2015 Q1 | -15.4 Million USD | -8.37% |
| 2014 Q2 | -13.3 Million USD | 37.92% |
| 2014 Q1 | -21.42 Million USD | -112.58% |
| 2014 Q4 | -14.21 Million USD | -1.68% |
| 2014 FY | -62.91 Million USD | -19.96% |
| 2014 Q3 | -13.97 Million USD | -5.07% |
| 2013 Q2 | -11.82 Million USD | 45.38% |
| 2013 Q1 | -21.65 Million USD | -98.67% |
| 2013 FY | -52.44 Million USD | 9.97% |
| 2013 Q4 | -10.07 Million USD | -13.46% |
| 2013 Q3 | -8.88 Million USD | 24.9% |
| 2012 FY | -58.25 Million USD | -29.86% |
| 2012 Q4 | -10.9 Million USD | 0.0% |
| 2011 FY | -44.86 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Caribou Biosciences, Inc. | -102.07 Million USD | -217.415% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1602.601% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -821.986% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -534.545% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -60.714% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -144.531% |
| Agenus Inc. | -245.76 Million USD | -31.83% |
| Fortress Biotech, Inc. | -60.63 Million USD | -434.304% |
| GlycoMimetics, Inc. | -36.89 Million USD | -778.025% |
| Novavax, Inc. | -545.06 Million USD | 40.56% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -111.767% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -34513.889% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -230.103% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -4746.462% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -523.95% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 26.407% |
| AlloVir, Inc. | -190.41 Million USD | -70.145% |
| Aptorum Group Limited | -2.82 Million USD | -11369.964% |
| Ardelyx, Inc. | -66.06 Million USD | -390.39% |
| Bicycle Therapeutics plc | -180.66 Million USD | -79.331% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -80.944% |
| Chimerix, Inc. | -82.09 Million USD | -294.648% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -626.372% |
| CRISPR Therapeutics AG | -153.61 Million USD | -110.915% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -897.34% |
| Precision BioSciences, Inc. | -61.31 Million USD | -428.362% |
| Dyadic International, Inc. | -6.79 Million USD | -4667.682% |
| Elevation Oncology, Inc. | -45.7 Million USD | -608.879% |
| Fortress Biotech, Inc. | -60.63 Million USD | -434.304% |
| GT Biopharma, Inc. | -7.59 Million USD | -4164.657% |
| Alkermes plc | 355.75 Million USD | 191.069% |
| Immix Biopharma, Inc. | -15.42 Million USD | -2000.253% |
| Innoviva, Inc. | 179.72 Million USD | 280.271% |
| IO Biotech, Inc. | -86.08 Million USD | -276.365% |
| Jaguar Health, Inc. | -41.3 Million USD | -684.47% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 721.21% |
| ContextLogic Inc. | -317 Million USD | -2.204% |
| AbCellera Biologics Inc. | -146.39 Million USD | -121.305% |
| Lantern Pharma Inc. | -15.96 Million USD | -1929.792% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -3711.152% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -57.83% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 13.287% |
| MEI Pharma, Inc. | 17.77 Million USD | 1922.398% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -341.717% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1231.123% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -129.119% |
| NextCure, Inc. | -62.72 Million USD | -416.535% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -297.139% |
| ChromaDex Corporation | -4.93 Million USD | -6461.077% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -186.812% |
| Incyte Corporation | 597.59 Million USD | 154.215% |
| Opthea Limited | -220.24 Million USD | -47.104% |
| MiMedx Group, Inc. | 67.43 Million USD | 580.413% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -449.29% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -392.642% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -533.292% |
| Vaxcyte, Inc. | -402.26 Million USD | 19.46% |
| PDS Biotechnology Corporation | -42.94 Million USD | -654.47% |
| Pharming Group N.V. | -10.54 Million USD | -2971.54% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -1220.075% |
| Onconetix, Inc. | -37.4 Million USD | -766.048% |
| Acelyrin, Inc. | -381.64 Million USD | 15.107% |
| PureTech Health plc | -65.69 Million USD | -393.152% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -339.065% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -52.665% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1646.923% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -1231.123% |
| ESSA Pharma Inc. | -26.58 Million USD | -1118.802% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -1191.244% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -3144.402% |
| Seer, Inc. | -86.27 Million USD | -275.518% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -25.658% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -767.665% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1089.463% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -2582966.312% |
| Summit Therapeutics Inc. | -614.92 Million USD | 47.313% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -850.078% |
| Senti Biosciences, Inc. | -92.91 Million USD | -248.676% |
| ImmuCell Corporation | -5.77 Million USD | -5510.538% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -96.863% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -455.789% |
| Precigen, Inc. | -95.9 Million USD | -237.823% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -495.322% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -720.654% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -209.445% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -420.418% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -2378.499% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 43.442% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -383.597% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1003.419% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1038.711% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1496.698% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -463.327% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -101.324% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -8929.71% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -34.233% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 553.698% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -559.581% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -3156.878% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -31.919% |
| Aptose Biosciences Inc. | -51.2 Million USD | -532.699% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -229.596% |
| Soligenix, Inc. | -6.14 Million USD | -5176.018% |
| Century Therapeutics, Inc. | -136.67 Million USD | -137.052% |
| Kura Oncology, Inc. | -152.63 Million USD | -112.267% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -263.14% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2974.454% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 57394.994% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -56839.543% |
| Autolus Therapeutics plc | -208.38 Million USD | -55.476% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -350.619% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -357.64% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1395.228% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -43.834% |
| GRI Bio, Inc. | -13.03 Million USD | -2385.127% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -7736.011% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -161.102% |
| IGM Biosciences, Inc. | -246.41 Million USD | -31.479% |
| INmune Bio, Inc. | -30 Million USD | -979.665% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -193.044% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -667.852% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1929.777% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1951.196% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -442.827% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -220.249% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -17.333% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -36.19% |
| Verastem, Inc. | -87.36 Million USD | -270.833% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -497.893% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -100.814% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -177.723% |
| Histogen Inc. | -10.62 Million USD | -2950.428% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -2167.737% |
| Surrozen, Inc. | -43.04 Million USD | -652.721% |
| Organovo Holdings, Inc. | -14.67 Million USD | -2108.343% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -6268.865% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -519.015% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -1182.453% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1102.71% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -3776.782% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -114.44% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -562.195% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -989.944% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -3009.956% |
| Apollomics, Inc. | -172.6 Million USD | -87.708% |
| Amarin Corporation plc | -59.11 Million USD | -448.088% |
| Mesoblast Limited | -87.95 Million USD | -268.35% |
| Turnstone Biologics Corp. | -55.2 Million USD | -486.931% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -120.456% |
| Synaptogenix, Inc. | -6.03 Million USD | -5265.336% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1898.926% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -315.26% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -6661.73% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -3755.968% |
| Exelixis, Inc. | 207.76 Million USD | 255.939% |
| Better Therapeutics, Inc. | -39.76 Million USD | -714.854% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -125.072% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 38.712% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2561.726% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -4056.496% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -953.647% |
| Gritstone bio, Inc. | -138.49 Million USD | -133.942% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -402.577% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -7999.751% |
| Avid Bioservices, Inc. | -140.75 Million USD | -130.181% |
| Insmed Incorporated | -749.56 Million USD | 56.777% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -2032.959% |
| MediWound Ltd. | -6.71 Million USD | -4724.092% |
| OmniAb, Inc. | -50.61 Million USD | -540.048% |
| Alector, Inc. | -130.39 Million USD | -148.473% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -184.888% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -524.889% |
| Zai Lab Limited | -334.62 Million USD | 3.178% |
| Aura Biosciences, Inc. | -76.4 Million USD | -324.021% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -38.083% |
| Immunic, Inc. | -93.61 Million USD | -246.095% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -138.413% |
| Veracyte, Inc. | -74.4 Million USD | -335.442% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -4121.013% |
| FibroGen, Inc. | -284.23 Million USD | -13.986% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1135.079% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -4527.122% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1620.338% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 178.101% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -1336.427% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 757.559% |
| TG Therapeutics, Inc. | 12.67 Million USD | 2656.708% |
| Galecto, Inc. | -38.34 Million USD | -744.836% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1617.301% |
| Fortrea Holdings Inc. | -3.4 Million USD | -9429.0% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -155.824% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1760.812% |
| XBiotech Inc. | -24.55 Million USD | -1219.322% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -402.577% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -416.889% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -229.167% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1412.046% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -487.006% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 46.593% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -374.67% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -568955.397% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -43.016% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -1354.971% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -47.461% |
| NexImmune, Inc. | -32.34 Million USD | -901.676% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -6028.468% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -2206.624% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 108.195% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -1237.624% |
| Scopus BioPharma Inc. | -11.6 Million USD | -2690.619% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -177.39% |
| Ainos, Inc. | -13.77 Million USD | -2252.746% |
| Pluri Inc. | -20.88 Million USD | -1451.063% |
| Prothena Corporation plc | -147.02 Million USD | -120.357% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -184.52% |
| Celularity Inc. | -196.29 Million USD | -65.051% |
| Rallybio Corporation | -74.56 Million USD | -334.507% |
| Cue Biopharma, Inc. | -50.73 Million USD | -538.61% |
| MeiraGTx Holdings plc | -84.02 Million USD | -285.574% |
| Omeros Corporation | -117.81 Million USD | -175.0% |
| Humacyte, Inc. | -110.77 Million USD | -192.469% |
| Immunocore Holdings plc | -55.28 Million USD | -486.008% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1701.524% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -1312.873% |
| Blueprint Medicines Corporation | -506.98 Million USD | 36.095% |
| CalciMedica, Inc. | -34.35 Million USD | -842.999% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -378.738% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -95.421% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -14.38% |
| Pulmatrix, Inc. | -14.12 Million USD | -2194.356% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -820.546% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -292.055% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 32.67% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -208.938% |
| Cytokinetics, Incorporated | -526.24 Million USD | 38.434% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -798.339% |
| Nutriband Inc. | -5.48 Million USD | -5806.426% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -701.549% |
| Vor Biopharma Inc. | -117.86 Million USD | -174.884% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 107.45% |
| Evogene Ltd. | -23.87 Million USD | -1256.782% |
| ProKidney Corp. | -35.46 Million USD | -813.46% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -170.523% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -4029.635% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 49.629% |
| CorMedix Inc. | -46.33 Million USD | -599.161% |
| BioLineRx Ltd. | -60.61 Million USD | -434.507% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -218.433% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -688.94% |
| Atai Life Sciences N.V. | -40.22 Million USD | -705.454% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -301.718% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -329.001% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -10.882% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1062.24% |
| MediciNova, Inc. | -8.57 Million USD | -3679.798% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -162.811% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3767.643% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1147.695% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -35.424% |
| Biomea Fusion, Inc. | -117.25 Million USD | -176.309% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 48.295% |
| Mereo BioPharma Group plc | -29.46 Million USD | -999.525% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -111.532% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -54.751% |
| Absci Corporation | -110.56 Million USD | -193.025% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -974.58% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -221.297% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -37.319% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 2400.383% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -67.901% |
| Allakos Inc. | -185.7 Million USD | -74.466% |
| Imunon, Inc. | -19.51 Million USD | -1560.192% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -232.857% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 405.244% |
| BioAtla, Inc. | -123.46 Million USD | -162.418% |
| NLS Pharmaceutics AG | -12.17 Million USD | -2561.726% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1915.089% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 1.002% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -776.846% |
| XOMA Corporation | -40.83 Million USD | -693.48% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -218.039% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -173.376% |
| aTyr Pharma, Inc. | -50.38 Million USD | -542.97% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -269.514% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -113.487% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -36.281% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -822.538% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -3903.811% |
| Akari Therapeutics, Plc | -10 Million USD | -3137.27% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -481126.885% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 215.054% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4761.079% |
| UroGen Pharma Ltd. | -102.24 Million USD | -216.875% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -203.378% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -4065.852% |
| Orgenesis Inc. | -55.36 Million USD | -485.224% |
| Entera Bio Ltd. | -8.88 Million USD | -3544.797% |
| GH Research PLC | -35.58 Million USD | -810.405% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1454.635% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -318.651% |
| Xencor, Inc. | -126.08 Million USD | -156.954% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -8503.602% |
| Replimune Group, Inc. | -215.79 Million USD | -50.137% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1423.454% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 13012.953% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -4761.079% |
| Portage Biotech Inc. | -75.33 Million USD | -330.038% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -3767.643% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -235.198% |
| OncoCyte Corporation | -27.78 Million USD | -1066.214% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -2314.704% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2813.145% |
| Purple Biotech Ltd. | -19.88 Million USD | -1529.708% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -4515.843% |
| scPharmaceuticals Inc. | -54.81 Million USD | -491.107% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1750.699% |
| HilleVax, Inc. | -123.56 Million USD | -162.197% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -3105.561% |
| Tharimmune, Inc. | -9.31 Million USD | -3376.583% |
| Genprex, Inc. | -30.86 Million USD | -949.842% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -37.326% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -976.58% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -18081.033% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -6017.543% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1925469.94% |
| Savara Inc. | -54.69 Million USD | -492.318% |
| Curis, Inc. | -47.41 Million USD | -583.327% |
| Daré Bioscience, Inc. | -30.16 Million USD | -974.175% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1997.664% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -5717.669% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -986.654% |
| BeiGene, Ltd. | -881.7 Million USD | 63.255% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1421.49% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 25.754% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -310.343% |
| Erasca, Inc. | -125.04 Million USD | -159.102% |
| bluebird bio, Inc. | -211.91 Million USD | -52.886% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -6379.076% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 293.257% |
| DBV Technologies S.A. | -72.72 Million USD | -345.489% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -6379.076% |
| Moderna, Inc. | -4.71 Billion USD | 93.127% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -706.798% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -5589.954% |
| Molecular Templates, Inc. | -8.12 Million USD | -3888.011% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -436.507% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -190.834% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -139.366% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -576.112% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -129.08% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -68.383% |
| MacroGenics, Inc. | -9.05 Million USD | -3476.794% |
| RenovoRx, Inc. | -10.23 Million USD | -3066.4% |
| Adicet Bio, Inc. | -142.65 Million USD | -127.107% |
| Prime Medicine, Inc. | -198.13 Million USD | -63.519% |
| Aditxt, Inc. | -32.38 Million USD | -900.549% |
| Adagene Inc. | -18.94 Million USD | -1610.016% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4331.049% |
| Quantum-Si incorporated | -95.96 Million USD | -237.626% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -172.191% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2122.466% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 344.832% |
| SciSparc Ltd. | -5.12 Million USD | -6225.381% |
| Vericel Corporation | -3.18 Million USD | -10081.835% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -269318.065% |
| Minerva Neurosciences, Inc. | -30 Million USD | -979.761% |
| Generation Bio Co. | -126.61 Million USD | -155.889% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -344.48% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -292.987% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -23.593% |
| Invivyd, Inc. | -198.64 Million USD | -63.1% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 5.26% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -3629.733% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1520.617% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -3181.203% |
| 2seventy bio, Inc. | -217.57 Million USD | -48.911% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1047.3% |
| Clene Inc. | -49.5 Million USD | -554.464% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -1353.664% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -555.391% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1147.695% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 1.244% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -895.565% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1525.995% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -227.948% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -333.403% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -101.478% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 47.325% |
| Evaxion Biotech A/S | -22.12 Million USD | -1364.344% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -301.291% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -61.938% |
| Trevena, Inc. | -40.28 Million USD | -704.155% |
| Surrozen, Inc. | -43.04 Million USD | -652.721% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -368.635% |
| Cingulate Inc. | -23.53 Million USD | -1276.617% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -4587.297% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -712.81% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -4101.786% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -259.146% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -428.646% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -444.487% |
| Clearmind Medicine Inc. | -11.95 Million USD | -2610.039% |
| Kronos Bio, Inc. | -112.67 Million USD | -187.545% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -368.208% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -12774214.632% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -277.188% |
| Statera Biopharma, Inc. | -174.4 Million USD | -85.763% |
| ImmunityBio, Inc. | -583.19 Million USD | 44.446% |
| Korro Bio, Inc. | -81.17 Million USD | -299.135% |
| Kineta, Inc. | -14.09 Million USD | -2197.936% |
| BioVie Inc. | -32.12 Million USD | -908.657% |
| Codexis, Inc. | -76.24 Million USD | -324.955% |
| Celularity Inc. | -196.29 Million USD | -65.051% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -51.022% |
| Celcuity Inc. | -63.77 Million USD | -407.981% |
| Virax Biolabs Group Limited | -6.73 Million USD | -4711.528% |
| Cibus, Inc. | -267.62 Million USD | -21.059% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -703.417% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -804.711% |
| IN8bio, Inc. | -30 Million USD | -979.701% |
| Kodiak Sciences Inc. | -260.49 Million USD | -24.375% |
| Annexon, Inc. | -134.23 Million USD | -141.354% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -176.521% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -429.147% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -927.092% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 11.548% |
| Eyenovia, Inc. | -27.26 Million USD | -1088.456% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1600.56% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -60458.131% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -324.043% |
| Arcellx, Inc. | -70.69 Million USD | -358.319% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -681.801% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -142.113% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -978.623% |
| Moolec Science SA | -51.78 Million USD | -525.59% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -518.636% |
| Geron Corporation | -184.12 Million USD | -75.958% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -671.873% |
| Royalty Pharma plc | 1.13 Billion USD | 128.549% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -138.302% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -3543.648% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1425.126% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -88.726% |
| Humacyte, Inc. | -110.77 Million USD | -192.469% |
| Structure Therapeutics Inc. | -89.62 Million USD | -261.511% |
| 89bio, Inc. | -142.18 Million USD | -127.856% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -369.817% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -3022.155% |
| Genelux Corporation | -28.29 Million USD | -1044.948% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1014.695% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -82.92% |
| Notable Labs, Ltd. | -11.26 Million USD | -2776.296% |
| Liquidia Corporation | -78.5 Million USD | -312.711% |
| Mustang Bio, Inc. | -51.6 Million USD | -527.856% |
| Immunovant, Inc. | -259.33 Million USD | -24.929% |
| Quantum-Si incorporated | -95.96 Million USD | -237.626% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -344.736% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1571.668% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -237.521% |
| Acasti Pharma Inc. | -12.85 Million USD | -2420.703% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -1342.64% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1929.777% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -77.631% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -7431.901% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -2498.123% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -998.593% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -730.989% |
| PepGen Inc. | -78.62 Million USD | -312.06% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -988.334% |
| United Therapeutics Corporation | 984.8 Million USD | 132.899% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -1355.463% |
| Solid Biosciences Inc. | -96.01 Million USD | -237.433% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -6661.73% |
| Immuneering Corporation | -53.47 Million USD | -505.903% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -6268.865% |
| Silo Pharma, Inc. | -3.7 Million USD | -8654.762% |
| Belite Bio, Inc | -31.63 Million USD | -924.235% |
| XOMA Corporation | -40.83 Million USD | -693.48% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -495.946% |
| Bionomics Limited | -15.49 Billion USD | 97.909% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -285.767% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1011.177% |
| uniQure N.V. | -308.47 Million USD | -5.027% |
| Cassava Sciences, Inc. | -97.21 Million USD | -233.261% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4331.049% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -162.486% |
| Forte Biosciences, Inc. | -31.47 Million USD | -929.311% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -3850.228% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1014.58% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -60458.131% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1135.079% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1865.338% |
| Altimmune, Inc. | -88.44 Million USD | -266.305% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -113.734% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1011.177% |
| Compugen Ltd. | -18.75 Million USD | -1627.557% |
| Peak Bio, Inc. | -1259.26 USD | -25728184.866% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -603.568% |
| Benitec Biopharma Inc. | -21.75 Million USD | -1389.522% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 4.37% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -290.561% |
| Zura Bio Limited | -60.36 Million USD | -436.756% |
| PolyPid Ltd. | -23.86 Million USD | -1257.578% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1959.408% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -290.561% |
| Instil Bio, Inc. | -156.08 Million USD | -107.568% |
| argenx SE | -295.05 Million USD | -9.806% |
| Immunome, Inc. | -106.8 Million USD | -203.341% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -662.428% |
| Verona Pharma plc | -54.36 Million USD | -495.902% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -224.255% |
| Shattuck Labs, Inc. | -87.29 Million USD | -271.126% |
| CervoMed Inc. | -2.17 Million USD | -14817.355% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -159.914% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -2333.058% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -643.855% |
| Moolec Science SA | -51.78 Million USD | -525.59% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1873547.113% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -139.781% |
| AnaptysBio, Inc. | -163.61 Million USD | -98.012% |
| Design Therapeutics, Inc. | -66.86 Million USD | -384.559% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -297.949% |
| NeurAxis, Inc. | -14.62 Million USD | -2115.034% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -755.251% |
| Lumos Pharma, Inc. | -34.03 Million USD | -851.948% |
| Achilles Therapeutics plc | -69.66 Million USD | -365.063% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -224.255% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1525.203% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 10867.983% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -12774214.632% |
| Nutriband Inc. | -5.48 Million USD | -5806.426% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -221.743% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -566.542% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -320.264% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -853.742% |
| MoonLake Immunotherapeutics | -36 Million USD | -799.78% |
| Palisade Bio, Inc. | -12.3 Million USD | -2534.033% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -669.124% |
| Beam Therapeutics Inc. | -132.52 Million USD | -144.468% |
| Neurogene Inc. | -36.31 Million USD | -792.106% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -98.26% |
| AEON Biopharma, Inc. | -52.55 Million USD | -516.459% |
| Sesen Bio, Inc. | -19.88 Million USD | -1529.38% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -352.596% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -2489.01% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 27.036% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -190.399% |
| Athira Pharma, Inc. | -117.67 Million USD | -175.33% |
| Vaccinex, Inc. | -20.25 Million USD | -1499.852% |
| HCW Biologics Inc. | -24.99 Million USD | -1196.241% |
| XOMA Corporation | -40.83 Million USD | -693.48% |
| Nektar Therapeutics | -276.05 Million USD | -17.362% |
| Arvinas, Inc. | -367.3 Million USD | 11.793% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -481126.885% |
| Merus N.V. | -154.93 Million USD | -109.106% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -232.539% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -932.296% |
| Rezolute, Inc. | -68.45 Million USD | -373.256% |
| Clene Inc. | -49.5 Million USD | -554.464% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2000.604% |
| BeyondSpring Inc. | -21.02 Million USD | -1440.883% |
| Synlogic, Inc. | -57.28 Million USD | -465.598% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -2622.343% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2892.666% |
| Peak Bio, Inc. | -1259.26 USD | -25728184.866% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -767.015% |
| Krystal Biotech, Inc. | 10.93 Million USD | 3063.648% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -126.407% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 0.344% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -6914.255% |
| MannKind Corporation | -11.93 Million USD | -2613.905% |
| Ikena Oncology, Inc. | -68.16 Million USD | -375.29% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1441.689% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -248.623% |
| Gossamer Bio, Inc. | -179.81 Million USD | -80.175% |
| CohBar, Inc. | -11.96 Million USD | -2608.433% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1156.344% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -974.58% |
| Legend Biotech Corporation | -518.25 Million USD | 37.485% |
| Mural Oncology plc | -207.44 Million USD | -56.178% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -161.037% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1671.41% |
| Disc Medicine, Inc. | -76.42 Million USD | -323.905% |
| Champions Oncology, Inc. | -7.27 Million USD | -4352.804% |
| REGENXBIO Inc. | -263.49 Million USD | -22.958% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2952.707% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -582.004% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -752.965% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -223.459% |
| Vaxart, Inc. | -82.46 Million USD | -292.877% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 97170.676% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -762.984% |
| Cellectis S.A. | -101.05 Million USD | -220.591% |
| Longeveron Inc. | -21.41 Million USD | -1413.034% |
| Repare Therapeutics Inc. | -93.79 Million USD | -245.416% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 39.552% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -355.235% |
| Revolution Medicines, Inc. | -436.36 Million USD | 25.754% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -4830.543% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -951.084% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -367.29% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -400.504% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -3202.273% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 108.951% |
| Denali Therapeutics Inc. | -145.22 Million USD | -123.094% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -269318.065% |
| Veru Inc. | -93.15 Million USD | -247.801% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1098.661% |
| Cingulate Inc. | -23.53 Million USD | -1276.617% |
| Passage Bio, Inc. | -102.06 Million USD | -217.44% |
| Context Therapeutics Inc. | -23.96 Million USD | -1251.958% |
| Exicure, Inc. | -16.91 Million USD | -1815.49% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -71.496% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -757.923% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -4878.79% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -75.433% |
| Nuvalent, Inc. | -126.21 Million USD | -156.686% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2980.987% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -272.916% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -960.719% |
| OmniAb, Inc. | -50.61 Million USD | -540.048% |
| Anew Medical, Inc. | 1.34 Million USD | 24168.047% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1919.233% |
| Lipocine Inc. | -16.35 Million USD | -1881.313% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -387.975% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -408.812% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -667.852% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -575.435% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1533.735% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 40.168% |
| Ocugen, Inc. | -63.07 Million USD | -413.628% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -238.43% |
| Q32 Bio Inc. | -112.96 Million USD | -186.812% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1784.516% |
| Alumis Inc. Common Stock | -154.99 Million USD | -109.033% |
| Equillium, Inc. | -13.33 Million USD | -2329.591% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -436.703% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -3955.992% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1618.647% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -448.367% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -182.89% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1662.906% |
| Dominari Holdings Inc. | -22.88 Million USD | -1315.899% |
| Edesa Biotech, Inc. | -8.37 Million USD | -3768.76% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1499.931% |
| Bio-Techne Corporation | 168.1 Million USD | 292.728% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 7.982% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 351.438% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -165.928% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -753.966% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -187.625% |
| Nkarta, Inc. | -117.5 Million USD | -175.73% |
| BioCardia, Inc. | -11.57 Million USD | -2699.983% |
| Iterum Therapeutics plc | -38.37 Million USD | -744.351% |